Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
Condition(s):Candida VulvovaginitisLast Updated:September 8, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Candida VulvovaginitisLast Updated:September 8, 2021Completed
Condition(s):HIV-1 InfectionLast Updated:February 16, 2015Completed
Condition(s):Candida VulvovaginitisLast Updated:September 8, 2021Completed
Condition(s):Candida VulvovaginitisLast Updated:August 12, 2021Completed
Condition(s):Vulvovaginal Candidiasis; Vaginal Yeast InfectionsLast Updated:June 13, 2023Recruiting
Condition(s):Vulvovaginal CandidiasisLast Updated:January 18, 2024Completed
Condition(s):Fluconazole; Candidiasis; Invasive Fungal Infections; ObesityLast Updated:July 14, 2021Completed
Condition(s):CandidiasisLast Updated:October 3, 2011Completed
Condition(s):Invasive CandidiasisLast Updated:May 30, 2011Completed
Condition(s):Vaginal CandidiasisLast Updated:May 30, 2007Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.